Protection by the alkyllysophospholipid, 1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine, but not by the retinoid etretinate against leukemia development in DMBA-treated Long-Evans rats
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 30 (1) , 73-78
- https://doi.org/10.1016/0304-3835(86)90134-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- 7,12-Dimethylbenz[a]anthracene-DNA adducts in Sprague-Dawley and Long-Evans female rats: the relationship of DNA adducts to mammary cancerCarcinogenesis: Integrative Cancer Research, 1984
- Influence of the Alkyllysophospholipid ET-18-OCH3 on Methylnitrosourea-induced Rat Mammary CarcinomasOncology, 1984
- Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2′-dithio-bis-ethane sulfonate (dimesna)Cancer, 1983
- Early tumor and leukemia response to alkyl-lysophospholipids in a phase I studyCancer, 1982
- ENHANCED INHIBITION OF MAMMARY CARCINOGENESIS BY COMBINED TREATMENT WITH N-(4-HYDROXYPHENYL)RETINAMIDE AND OVARIECTOMY1982
- Chemotherapy of autochthonous leukemias induced by 7,12-dimethylbenz(a)anthracene in long evans ratsZeitschrift für Krebsforschung und Klinische Onkologie, 1980
- N-(4-HYDROXYPHENYL)RETINAMIDE - NEW RETINOID FOR PREVENTION OF BREAST-CANCER IN THE RAT1979
- INHIBITION OF MAMMARY-CANCER BY RETINYL METHYL-ETHER1977